Logo image of FCUV

FOCUS UNIVERSAL INC (FCUV) Stock Fundamental Analysis

NASDAQ:FCUV - Nasdaq - US34417J1043 - Common Stock - Currency: USD

4.93  -0.02 (-0.4%)

Fundamental Rating

2

FCUV gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 124 industry peers in the Electronic Equipment, Instruments & Components industry. FCUV scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. FCUV is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

0

1. Profitability

1.1 Basic Checks

FCUV had negative earnings in the past year.
In the past year FCUV has reported a negative cash flow from operations.
FCUV had negative earnings in each of the past 5 years.
FCUV had a negative operating cash flow in each of the past 5 years.
FCUV Yearly Net Income VS EBIT VS OCF VS FCFFCUV Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 -2M -4M -6M

1.2 Ratios

The Return On Assets of FCUV (-66.96%) is worse than 89.17% of its industry peers.
FCUV has a Return On Equity of -76.61%. This is amonst the worse of the industry: FCUV underperforms 82.50% of its industry peers.
Industry RankSector Rank
ROA -66.96%
ROE -76.61%
ROIC N/A
ROA(3y)-54.77%
ROA(5y)-50.75%
ROE(3y)-73.71%
ROE(5y)-64.32%
ROIC(3y)N/A
ROIC(5y)N/A
FCUV Yearly ROA, ROE, ROICFCUV Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 -1K -2K -3K -4K

1.3 Margins

FCUV does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
FCUV Yearly Profit, Operating, Gross MarginsFCUV Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 -500 -1K

6

2. Health

2.1 Basic Checks

FCUV does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for FCUV has been reduced compared to 1 year ago.
Compared to 5 years ago, FCUV has more shares outstanding
FCUV has a worse debt/assets ratio than last year.
FCUV Yearly Shares OutstandingFCUV Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 20M 40M 60M
FCUV Yearly Total Debt VS Total AssetsFCUV Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 5M 10M

2.2 Solvency

FCUV has an Altman-Z score of 267.96. This indicates that FCUV is financially healthy and has little risk of bankruptcy at the moment.
With an excellent Altman-Z score value of 267.96, FCUV belongs to the best of the industry, outperforming 100.00% of the companies in the same industry.
FCUV has a Debt/Equity ratio of 0.01. This is a healthy value indicating a solid balance between debt and equity.
FCUV has a better Debt to Equity ratio (0.01) than 60.83% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF N/A
Altman-Z 267.96
ROIC/WACCN/A
WACC9.12%
FCUV Yearly LT Debt VS Equity VS FCFFCUV Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 5M -5M 10M

2.3 Liquidity

A Current Ratio of 7.82 indicates that FCUV has no problem at all paying its short term obligations.
Looking at the Current ratio, with a value of 7.82, FCUV belongs to the top of the industry, outperforming 90.00% of the companies in the same industry.
FCUV has a Quick Ratio of 7.19. This indicates that FCUV is financially healthy and has no problem in meeting its short term obligations.
With an excellent Quick ratio value of 7.19, FCUV belongs to the best of the industry, outperforming 91.67% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 7.82
Quick Ratio 7.19
FCUV Yearly Current Assets VS Current LiabilitesFCUV Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2M 4M 6M 8M

3

3. Growth

3.1 Past

FCUV shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 19.97%, which is quite good.
FCUV shows a decrease in Revenue. In the last year, the revenue decreased by -9.65%.
FCUV shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 27.69% yearly.
EPS 1Y (TTM)19.97%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%250.51%
Revenue 1Y (TTM)-9.65%
Revenue growth 3Y-14.44%
Revenue growth 5Y27.69%
Sales Q2Q%-76.69%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
FCUV Yearly Revenue VS EstimatesFCUV Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 500K 1M 1.5M
FCUV Yearly EPS VS EstimatesFCUV Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for FCUV. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
FCUV Price Earnings VS Forward Price EarningsFCUV Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
FCUV Per share dataFCUV EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.02 -0.02 0.04 -0.04 0.06 -0.06

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

No dividends for FCUV!.
Industry RankSector Rank
Dividend Yield N/A

FOCUS UNIVERSAL INC

NASDAQ:FCUV (2/11/2025, 6:26:50 PM)

4.93

-0.02 (-0.4%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupTechnology Hardware & Equipment
GICS IndustryElectronic Equipment, Instruments & Components
Earnings (Last)11-15 2024-11-15/bmo
Earnings (Next)03-31 2025-03-31
Inst Owners3.85%
Inst Owner Change-63.19%
Ins Owners54.01%
Ins Owner Change10.35%
Market Cap359.50M
Analysts0
Price TargetN/A
Short Float %N/A
Short Ratio0.3
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 469.03
P/FCF N/A
P/OCF N/A
P/B 66.02
P/tB 66.02
EV/EBITDA N/A
EPS(TTM)-0.06
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.06
FCFYN/A
OCF(TTM)-0.06
OCFYN/A
SpS0.01
BVpS0.07
TBVpS0.07
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -66.96%
ROE -76.61%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-54.77%
ROA(5y)-50.75%
ROE(3y)-73.71%
ROE(5y)-64.32%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover0.12
Health
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 16.01%
Cap/Sales 1.77%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 7.82
Quick Ratio 7.19
Altman-Z 267.96
F-Score3
WACC9.12%
ROIC/WACCN/A
Cap/Depr(3y)16.1%
Cap/Depr(5y)37.16%
Cap/Sales(3y)4.93%
Cap/Sales(5y)5.97%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)19.97%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%250.51%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-9.65%
Revenue growth 3Y-14.44%
Revenue growth 5Y27.69%
Sales Q2Q%-76.69%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-60.62%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-55.33%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-57.53%
OCF growth 3YN/A
OCF growth 5YN/A